FORMULATIONS AND METHODS FOR THE PREVENTION OF OPIOID OVERDOSE

• 1. 阿片类药物过量监测 [P] . 中国专利： CN112512406A . 2021-03-16
• 2. 阿片类与非阿片类镇痛药的控释制剂 [P] . 中国专利： CN102697704A . 2012-10-03
• 3. FORMULATIONS AND METHODS FOR THE PREVENTION OF OPIOID OVERDOSE [P] . EP3793558A1 . 2021-03-24

  机译： 预防阿片类药物过量的制剂和方法

• 4. METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE [P] . US2021275444A1 . 2021-09-09

  机译： 方法，肠胃外药物制剂和预防阿片类药物过量的装置

• 5. METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE [P] . EP3876937A1 . 2021-09-15

  机译： 方法，肠胃外药物制剂和预防阿片类药物过量的装置

• 1. Prevention and Control Effects of New Biological Formulations Sprayed by Different Methods on Proceras venosatus (Walker) and Tryporyza intacta Snellen in Middle and Late Stages [J] . Li Wenfeng, Shan Hongli, Wang Xiaoyan, 植物病虫害研究：英文版 . 2018,第003期
• 2. Commentary: “Ockham’s Razor” Doesn’t Apply to “Opioid” Overdose Death [J] . John F. Peppin, Joseph V. Pergolizzi Jr., Eugene Vortsman, 生物科学与医学（英文） . 2021,第001期
• 3. Commentary: New Complications Make Treatment of “Opioid” Overdose Challenging [J] . John F. Peppin, Joseph V. Pergolizzi Jr., Albert Dahan, 药理与制药（英文） . 2020,第012期
• 4. Leveraging Statistical Methods for an Analysis of Demographic Factors of Opioid Overdose Deaths [C] . Amna Alalawi, Daniel Fooks, Les Sztandera, International Conference on Data Analytics . 2020
• 5. Opioid Overdose Screening and Naloxone Co-prescribing to Curb Overdose Deaths [D] . Malik, Shamsah. 2021
• 6. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs [O] . N.A. Blackburn, K.E. Lancaster, T.V. Ha, 2017
• 7. Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose [O] . Megan Laudenbach, Federico Baruffaldi, Christine Robinson, 2018
• 8. Community-Based Opioid Overdose Prevention Programs Providing Naloxone: United States, 2010. Morbidity and Mortality Weekly Report, Vol. 61, No. 6, February 17, 2012 [R] . 2012

• 1. Efficacy and Tolerability of Long-Acting Injectable Formulation of Nalmefene (Nalmefene Consta 393.1 mg) for Opioid Relapse Prevention: A Multicentre, Open-Label, Randomised Controlled Trial [J] . Sead Kadric ,Hanns Mohler ,Olli Kallioniemi . 神经科学国际期刊（英文） . 2019,第3期
• 2. The Place of Community Rescue Naloxone in a Public Health Crisis of Opioid Overdose [J] . Joseph V. Pergolizzi ,Jo Ann LeQuang ,Robert Taylor . 药理与制药（英文） . 2019,第2期
• 3. 环氧合酶抑制剂在防治阿片类药物诱发的术后痛觉过敏中的作用 [C] . 张婧 ,徐世元 . 第十次全国麻醉学与复苏进展学术会议 . 2015
• 4. 癌痛患者阿片类药物所致便秘风险因素及预防的回顾性研究 [A] . 王淑云 . 2018